Loading...
OTCM
CPMV
Market cap2mUSD
Jul 09, Last price  
0.41USD
1D
-16.96%
1Q
-35.41%
Jan 2017
10,025.00%
Name

Mosaic Immunoengineering Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
55.45%
Rev. gr., 5y
%
Revenues
0k
358,809123,90376,4172,982,58610,309,709638,7843,708,2185,354,722567,934468,6780000000000
Net income
-2m
L-35.38%
-5,487,051-3,888,299-4,149,978-2,693,55028,672,68823,691,1879,388,321881,509-6,679,821-11,515,390-4,820,4051,096,215-1,466,867-1,538,028-1,266,600-45,368-1,209,450-798,463-3,684,478-2,380,870
CFO
-690k
L+1.60%
-3,632,534-1,885,762-2,075,972-628,3266,473,632-14,150,702-19,259,517-7,165,434-7,317,256-4,320,949-2,402,125-1,010,204-1,504,673-1,344,607-1,578,284-1,310,832-880,286-760,766-679,236-690,129
Earnings
Aug 12, 2025

Profile

Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
IPO date
Oct 28, 1993
Employees
4
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122020‑052018‑052017‑052016‑05
Income
Revenues
Cost of revenue
2,628
Unusual Expense (Income)
NOPBT
(2,628)
NOPBT Margin
Operating Taxes
2
Tax Rate
NOPAT
(2,630)
Net income
(2,381)
-35.38%
Dividends
Dividend yield
Proceeds from repurchase of equity
343
BB yield
-4.79%
Debt
Debt current
Long-term debt
1,228
Deferred revenue
Other long-term liabilities
Net debt
1,008
Cash flow
Cash from operating activities
(690)
CAPEX
Cash from investing activities
343
Cash from financing activities
342
FCF
(1,037)
Balance
Cash
221
Long term investments
Excess cash
221
Stockholders' equity
(6,908)
Invested Capital
3,252
ROIC
ROCE
71.86%
EV
Common stock shares outstanding
7,236
Price
0.99
-2.94%
Market cap
7,163
4.62%
EV
8,171
EBITDA
(2,628)
EV/EBITDA
Interest
152
Interest/NOPBT